Elinzanetant significantly reduced the frequency and severity of vasomotor symptoms, known as hot flashes, compared with ...

Clinicians need to address maternal health at all stages, with some seeing a possible new role for GLP-1 drugs.

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

Women who are carrying excess weight prior to pregnancy are more likely to develop complications like gestational diabetes ...

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) on Monday released topline results from the pivotal Phase 3 TRANSCEND trial ...

In patients with RA, BMI affects cardiovascular risk, differing by anti–citrullinated protein antibody (ACPA) status and ...

Q1 2025 Earnings Call Transcript April 17, 2025 Badger Meter, Inc. beats earnings expectations. Reported EPS is $1.3, ...

Among the 2,225 adults in the study, all under 60 years of age, 39.7% had obesity as defined only by higher BMI, while 39.1% ...

Badger Meter, Inc. ( NYSE: BMI) Q1 2025 Earnings Conference Call April 17, 2025 11:00 AM ET Karen Bauer - Vice President, Investor Relations, Corporate Strategy and Treasurer Kenneth Bockhorst - ...

Nearly all U.S. adults with obesity as diagnosed by BMI also have an elevated waist circumference or excess body fat, ...

Stifel analysts were bullish on the data, which showed a 16.5% drop in body-mass index among patients with damage to the ...